D. Çaðdaþ deniz.ayvaz@hacettepe.edu.tr¹, M. Pehlivantürk Kýzýlkan², A. Tagiyev², N. Emiralioðlu³, A. Keleþ⁴, E. Yalçýn³, D. Doðru³, U. Özçelik³, N. Kiper³, Ý. Tezcan¹

doi: 10.23822/EurAnnACI.1764-1489.151

Download PDF

Original Article

Are currently available biomarkers useful to discriminate CSU patients not controlled by low dose omalizumab maintenance therapy?

R. Asero r.asero@libero.it

doi: 10.23822/EurAnnACI.1764-1489.139

Download PDF

Original Article

Comparison of the performance of Skin Prick and ISAC Tests in the diagnosis of allergy

E. Scala e.scala@idi.it¹, D. Villalta¹, G. Meneguzzi¹, I. Brusca³, L. Cecchi⁴

doi: 10.23822/EurAnnACI.1764-1489.135

Download PDF

Review

Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes

C. Incorvaia¹, G. Ciprandi gio.cip@libero.it², M. C. Nizi³, E. Makri¹, E. Ridolo³

doi: 10.23822/EurAnnACI.1764-1489.150

Download PDF

Editorial

Allergy diagnostics: where are we going?

R. Asero¹, L. Cecchi²

doi: 10.23822/EurAnnACI.1764-1489.172

Download PDF

Allergy diagnostics: where are we going?

Authors Information

Table of Content: Vol. 52 (No. 6) 2020 November

Letter to the Editor

Letter to the Editor

Original Article

Original Article

Original Article

Original Article

Review

Editorial

Contact